Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05170854 · ClinicalTrials.gov registry record
The Impact of Liver Cirrhosis on Outcomes in Trauma Patients
A clinical trial of Cirrhosis, sponsored by Methodist Health System.
- Active
- Registry status
- 4,774,035
- Enrollment target
- 1
- Study location
NCT05170854 is a study of Cirrhosis that is active but no longer recruiting, run by Methodist Health System. The registered enrollment target is 4,774,035 participants, above the 333-participant average among 53 other Cirrhosis trials with a reported enrollment target (1433544% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05170854, a study of Cirrhosis, is active but no longer recruiting, sponsored by Methodist Health System.
- ACTIVE NOT RECRUITING
- Registry status
- 4,774,035 participants
- Enrollment target
- 1
- Study location
Study Summary
Given that there are only a few studies on the effects of cirrhosis on trauma patients and none have addressed the impact cirrhosis has on the incidence of infections, it is important that we study this to determine the mortality in cirrhotic trauma patients and ascertain the incidence of infectious complications in these patients. We hypothesize that trauma patients with cirrhosis will have higher rates of mortality and infectious complications.
Conditions Studied
Study Locations (1)
Texas
- Methodist Health System - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,774,035 participants |
| Start Date | 2018-10-16 |
| Est. Completion | 2026-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05170854
The ClinicalTrials.gov registry entry for NCT05170854 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 4,774,035 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 333-participant average among 53 other Cirrhosis trials with a reported enrollment target (1433544% higher). The listed sponsor is Methodist Health System, which has 125 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cirrhosis appearing as the primary indexed condition, and to 0 interventions.
NCT05170854 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05170854 about?
NCT05170854 is a clinical study titled "The Impact of Liver Cirrhosis on Outcomes in Trauma Patients". Given that there are only a few studies on the effects of cirrhosis on trauma patients and none have addressed the impact cirrhosis has on the incidence of infections, it is important that we study this to determine the mortality in cirrhotic trauma patients and ascertain the incidence of infectious...
What is the current status of trial NCT05170854?
This trial is currently active not recruiting. The enrollment target is 4,774,035 participants. The study started on 2018-10-16. Estimated completion is 2026-08.
What conditions does trial NCT05170854 study?
This clinical trial studies the following conditions: Cirrhosis.
Who is sponsoring clinical trial NCT05170854?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05170854 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cirrhosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mechanisms of Malnutrition in Cirrhosis With Portosystemic Shunting
RECRUITING
-
LiverSleep: A Behavioral Sleep Intervention for Patients With Cirrhosis and Insomnia
RECRUITING · NA
-
Droxidopa to Increase Mean Arterial Pressure in Decompensated Cirrhosis Patients With Acute Kidney Injury
RECRUITING · Phase 2
-
A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer
RECRUITING · Phase 2
-
Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis
RECRUITING · Phase 3
-
Hepatic Impairment With Cirrhosis Due to Cholestatic Liver Disease
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.